Institute for International Research

Covance, with headquarters in Princeton, New Jersey, US, is one of the world's largest and most comprehensive drug development services companies, with annual revenues greater than $1.9 billion and more than 10,000 employees in over 60 countries. Covance has the people, process, client service, and global resources to respond to biotechnology and pharmaceutical clients’ toughest drug development challenges.

With the most comprehensive portfolio of preclinical, clinical development, and commercialization services, Covance provides industry-leading services, the world’s largest central laboratory network, and a global team of clinical trial and commercialization experts. 

CRI Worldwide, a company with several locations in the mid-Atlantic region and abroad, is dedicated to performing early stage clinical trials.With over 65 beds located in fully licensed and accredited medical hospitals, CRI performs all types of clinical trials related to psychological and neurological disorders specializing in disease state populations.

Rosa Pharmaceuticals' Consulting Division helps clients systematically and dramatically improve development productivity through a combination of advanced predictive methods and proven organizational processes. Rosa's services include: Drug-Disease Modeling and Clinical Trial Simulation; Pharmaceutical Asset, Franchise, and Portfolio Strategy; and Dynamic Market Modeling and Forecasting. Rosa leaders have played a seminal role in establishing each of these areas' intellectual foundations, and they have generated extensive business value for clients during many years of professional experience. Rosa's clients develop drugs, diagnostics, and medical devices, and range in size from start-ups to major global pharmaceutical companies. Rosa serves clients worldwide from its offices in Silicon Valley, Seattle, Philadelphia, and London.

Clinilabs is a global, specialty CRO that provides clinical development services to life science companies involved in the development of central nervous system (CNS) and cardiovascular therapeutics. The Company offers a robust portfolio of services to fit the needs of any size client.